Skip to content
value.today

Intact Vascular, Inc.

🇺🇸 Wayne, Pennsylvania, USABiotechnologyFounded 2012
Total raised
$87 M
7 rounds on record
Latest round
$14 M
Apr 2020
First round on record
Aug 2012
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Intact Vascular, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2020$14 MNo. 7$10 to $50 million

Intact Vascular, Inc.: Raise no. 7, Apr 2020

Investors in this round

4 investors had bought by the notice of May 5, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $15 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,031,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce J. Shook · Executive Officer, Director
  • Douglas G. Evans · Executive Officer, Director
  • Joseph C. Griffin, III · Executive Officer
  • Monica W. Klos · Executive Officer
  • Peter G. Schneider · Executive Officer, Director
  • Bruce J. Robertson · Director
  • Dennis W. Wahr · Director
  • Josh G. Makower · Director
  • P. Sherrill Neff · Director
  • Peter Justin Klein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed May 5, 2020. Read the notice at the SEC.

debt, optionsSEC
May 2019$5 MNo. 6$2 to $10 million

Intact Vascular, Inc.: Raise no. 6, May 2019

Investors in this round

1 investor had bought by the notice of Jun 4, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $25 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$5,100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce J. Shook · Executive Officer, Director
  • Howard C. Rosen · Executive Officer
  • Joseph C. Griffin, III · Executive Officer
  • Marc C. Penna · Executive Officer
  • Michael C. Longo · Executive Officer
  • Monica W. Klos · Executive Officer
  • Stephen G. MacKinnon · Executive Officer
  • Bruce G. Robertson · Director
  • Dennis W. Wahr · Director
  • Douglas G. Evans · Director
  • Josh G. Makower · Director
  • P. Sherrill Neff · Director
  • Peter G. Schneider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed Jun 4, 2019. Read the notice at the SEC.

equity, optionsSEC
Apr 2018$10 MNo. 5$10 to $50 million

Intact Vascular, Inc.: Raise no. 5, Apr 2018

Investors in this round

3 investors had bought by the notice of Apr 13, 2018: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $22 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,100,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce J. Shook · Executive Officer, Director
  • Howard J. Rosen · Executive Officer
  • Joseph C. Griffin, III · Executive Officer
  • Marc C. Penna · Executive Officer
  • Michael G. Longo · Executive Officer
  • Monica G. Klos · Executive Officer
  • Aaron J. Davidson · Director
  • Dennis Sherrill Wahr · Director
  • Douglas G. Evans · Director
  • Justin J. Klein · Director
  • P. Sherrill Neff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce J. Shook, President, CEO. Source: SEC Form D, newest notice filed Apr 13, 2018. Read the notice at the SEC.

equity, optionsSEC
May 2015$39 MNo. 4$10 to $50 million

Intact Vascular, Inc.: Raise no. 4, May 2015

Investors in this round

8 investors had bought by the notice of Jan 17, 2017: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $39 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$4,900,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce J. Shook · Executive Officer, Director
  • Joseph C. Griffin, III · Executive Officer
  • Marc C. Penna · Executive Officer
  • Michael G. Longo · Executive Officer
  • Monica G. Klos · Executive Officer
  • Peter J. Schneider · Executive Officer, Director
  • Aaron J. Davidson · Director
  • Dennis Sherrill Wahr · Director
  • Douglas G. Evans · Director
  • Justin J. Klein · Director
  • P. Sherrill Neff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount does not include approximately $6.5 million in proceeds previously received by the company from the issuance and sale of convertible promissory notes that were converted into securities in connection with this offering.”

Signed by Bruce J. Shook, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 17, 2017. Read the notice at the SEC.

equitySEC
Mar 2015$3 MNo. 3$2 to $10 million

Intact Vascular, Inc.: Raise no. 3, Mar 2015

Investors in this round

15 investors had bought by the notice of Mar 19, 2015: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$710,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce J. Shook · Executive Officer, Director
  • Bryan A. Claseman · Executive Officer
  • Douglas G. Evans · Executive Officer, Director
  • Holly G. Harrity · Executive Officer
  • Joseph C. Griffin · Executive Officer
  • Marc G. Penna · Executive Officer
  • Aaron D. Davidson · Director
  • Dennis Sherrill Wahr · Director
  • Katherine D. Crothall · Director
  • P. Sherrill Neff · Director
  • Peter J. Schneider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bruce J. Shook, President and CEO. Source: SEC Form D, newest notice filed Mar 19, 2015. Read the notice at the SEC.

debt, optionsSEC
Dec 2013$5 MNo. 2$2 to $10 million

Intact Vascular, Inc.: Raise no. 2, Dec 2013

Investors in this round

5 investors had bought by the notice of Dec 20, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $9 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Security to be Acquired Upon Conversion of Debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$761,250 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carol A. Burns · Executive Officer, Director
  • Douglas G. Evans · Executive Officer, Director
  • Robert G. Giasolli · Executive Officer
  • Aaron D. Davidson · Director
  • Dennis Sherrill Wahr · Director
  • Katherine D. Crothall · Director
  • P. Sherrill Neff · Director
  • Peter A. Schneider · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carol A. Burns, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 20, 2013. Read the notice at the SEC.

equity, debtSEC
Aug 2012$11 MNo. 1$10 to $50 million

Intact Vascular, Inc.: Raise no. 1, Aug 2012

Investors in this round

42 investors had bought by the notice of Aug 30, 2012: 42 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $19 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Carol A. Burns · Executive Officer, Director
  • Robert D. Giasolli · Executive Officer
  • Scott H. Kruas · Executive Officer
  • Aaron D. Davidson · Director
  • Dennis H. Wahr · Director
  • Katherine D. Crothall · Director
  • Peter A. Schneider · Director
  • Wesley H. Kaupinen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes cash proceeds and proceeds of indebtedness of the Issuer converted in the offering”

Signed by Carol A. Burns, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 30, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Intact Vascular, Inc. chose not to state its revenue in its newest notice of a funding round (May 2020).

    SEC Form D · May 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2020

That is all the official record says: Intact Vascular, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Intact Vascular, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 42 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Intact Vascular, Inc.
NameRoleNamed in
Bruce J. ShookExecutive officerMay 2020
Douglas G. EvansExecutive officerMay 2020
Joseph C. Griffin, IIIExecutive officerMay 2020
Monica W. KlosExecutive officerMay 2020
Peter G. SchneiderExecutive officerMay 2020
Howard C. RosenExecutive officerJun 2019
Marc C. PennaExecutive officerJun 2019
Michael C. LongoExecutive officerJun 2019
Stephen G. MacKinnonExecutive officerJun 2019
Howard J. RosenExecutive officerApr 2018
Michael G. LongoExecutive officerApr 2018
Monica G. KlosExecutive officerApr 2018
Peter J. SchneiderExecutive officerJan 2017
Bryan A. ClasemanExecutive officerMay 2015
Holly G. HarrityExecutive officerMar 2015
Joseph C. GriffinExecutive officerMar 2015
Marc G. PennaExecutive officerMar 2015
Carol A. BurnsExecutive officerDec 2013
Robert G. GiasolliExecutive officerDec 2013
Robert D. GiasolliExecutive officerAug 2012
Scott H. KruasExecutive officerAug 2012
Bruce J. RobertsonDirectorMay 2020
Bruce J. ShookDirectorMay 2020
Dennis W. WahrDirectorMay 2020
Douglas G. EvansDirectorMay 2020
Josh G. MakowerDirectorMay 2020
P. Sherrill NeffDirectorMay 2020
Peter G. SchneiderDirectorMay 2020
Peter Justin KleinDirectorMay 2020
Bruce G. RobertsonDirectorJun 2019
Aaron J. DavidsonDirectorApr 2018
Dennis Sherrill WahrDirectorApr 2018
Justin J. KleinDirectorApr 2018
Peter J. SchneiderDirectorJan 2017
Aaron D. DavidsonDirectorMar 2015
Katherine D. CrothallDirectorMar 2015
Carol A. BurnsDirectorDec 2013
Peter A. SchneiderDirectorDec 2013
Dennis H. WahrDirectorAug 2012
Wesley H. KaupinenDirectorAug 2012